Home > Healthcare > Drug Device Combination > Therapeutic Systems > Scar Treatment Market

Scar Treatment Market - By Product (Topical [Cream, Gel], Laser [CO2, Pulse-dyed], Injectables), Type (Atrophic, Contracture, Hypertrophic & Keloid Scars, Stretch Marks), End-use (Hospitals, Clinics, Retail Pharmacies) – Global Forecast 2024 – 2032

  • Report ID: GMI8467
  • Published Date: Mar 2024
  • Report Format: PDF

Scar Treatment Market Size

Scar Treatment Market size generated over USD 23.8 billion in 2023 and is anticipated to register 9.6% CAGR between 2024 and 2032. Scar treatment encompasses a variety of methods, procedures, and products utilized to enhance the appearance, texture, and functionality of scars on the skin.
 

Scar Treatment Market

Moreover, several skin disorders, such as psoriasis, acne, eczema, and dermatitis, as well as traumatic injuries including surgical incisions, burns, and cuts are contributing to the growing demand for scar treatment. For instance, in 2022, as per the report from National Institute of Health (NIH), in Europe, around 5.5% of the population suffered from eczema, while the prevalence of psoriasis was 3.92%. Thus, as the incidence of these conditions rises worldwide, the need for effective scar management solutions will also increase.

Minimally invasive scar treatment techniques, such as laser therapy, injections, and microdermabrasion, are gaining popularity due to reduced risk, shorter treatment time and improved outcomes when compared to traditional surgery. Patients are increasingly seeking minimally invasive approaches for treating wounds, driving significant market expansion. However, the lack of awareness of advanced scar treatment options along with concerns related to side effects and complications may hamper the industry growth to some extent.
 

Scar Treatment Market Trends

Technological advances have greatly improved wound healing techniques over the years. These developments include new aesthetic medicines, laser treatments, advanced topical products, and other surgical procedures. For instance, new aesthetic medicines are estimated to cost USD 61 billion by 2032. Fractional laser technology has also grown popular as it allows precise debridement with minimal damage to surrounding tissue with advanced wound care facilities facilitating quick and effective wound repair. These technological advances have expanded wound treatment options for patients, improving outcomes and increasing patient satisfaction.
 

Moreover, techniques, such as laser treatments, microdermabrasion, chemical peels, and injectables allow patients to effectively reduce scarring with minimal discomfort and downtime. Increased preference for minimally invasive treatments is reflecting a broader trend towards less invasive and patient-friendly treatments across medical specialties. This shift is driven by rising patient demand for treatments that provide visible results with minimal disruption to their daily lives, further adding to the market development. 
 

Scar Treatment Market Analysis

Scar Treatment Market, By Product, 2021 – 2032 (USD Billion)

Based on product, the market is divided into injectables, topical products, laser products, and other products. The topical products segment, further bifurcated into silicon sheets, creams, gels, and other topical products, will generate over USD 23.6 billion by 2032. Improved formulations incorporating ingredients, such as silicone and plant extracts are enhancing the bioavailability of these agents, resulting in noticeable developments in scar appearance.

Moreover, the wide availability of topical products from over the counter and retail suppliers, makes them accessible to a wide range of patients. Increased awareness of the aesthetic impact of staining and continued investment in R&D activities will contribute to the segment growth.

Based on type, the scar treatment market is classified into contracture scars, atrophic scars, hypertrophic and keloid scars, and stretch marks. The atrophic scars segment was valued at over USD 8.5 billion in 2023. Degenerative scarring, usually the result of trauma, surgery, or injury, is commonly employed to significantly affect an individual’s self-esteem, leading to the demand for more effective treatment solutions.

Technological innovations in wound healing techniques, including topical treatments, laser treatments, and injectables, have expanded the options for management of soft wounds to further improve treatment effectiveness. Increasing disposable incomes and higher healthcare costs will fuel the segment growth, enabling individuals to invest in scar treatment products to improve their appearance.  
 

Scar Treatment Market, By Type (2023)

Based on end-use, the scar treatment market is divided into retail pharmacies, hospitals, medical spa, clinics, and others. The hospitals segment accounted for over USD 8.8 billion in 2023 and will exceed USD 20 billion by 2032. Hospitals have emerged as major centers for advanced wound care services for offering a wide range of advanced treatments including interventional surgery, laser treatments and specialist wound care clinics. Patients with complex or severe wounds often seek treatment in hospitals, where specialized expertise and state-of-the-art facilities are available. Moreover, these healthcare settings are equipped to handle a variety of patient types and provide integrated care strategies, making them the preferred option for many individuals seeking effective wound management.
 

North America Scar Treatment Market, 2020 – 2032 (USD Billion)

North America scar treatment market held a significant share in 2023 and will exceed a revenue of USD 21.9 billion by 2032. The well-established healthcare system and advanced medical technology in the region are facilitating the access to new wound treatment and primary care options.

Additionally, the high prevalence of skin diseases, traumatic injuries and aesthetic problems is driving the demand for wound healing. Increasing awareness of scar management and beauty enhancement is also favoring the regional market growth, with individuals seeking effective solutions to significantly improve their skin and quality of life. 
 

Scar Treatment Market Share

The scar treatment industry is competitive, comprising large multinationals and many small as well as medium-sized companies. These market players are working on the development and introduction of new advanced products and services based on various technologies to widen their customer base and global presence.
 

Scar Treatment Market Companies

Some of the eminent industry participants operating in the scar treatment industry include:

  • CCA Industries, Inc.
  • Suneva Medical
  • Clayton, Dubilier & Rice, LLC
  • Sonoma Pharmaceuticals, Inc.
  • Lumenis Be Ltd.
  • SMITH & NEPHEW plc
  • McKesson Corporation
  • Perrigo Company plc
  • Merz Pharma GmbH & Co. KGaA
  • Newmedical Technology Inc.
     

Scar Treatment Industry News:

  • In January 2023, Sonoma Pharmaceuticals, Inc. introduced a range of go-to office products specifically designed for skin care professionals.
     
  • In March 2024, the U.S. FDA approved Rezdiffra (resmetirom), which is used for treating adults with NASH (noncirrhotic non-alcoholic steatohepatitis) with moderate or advanced liver scarring
     

The scar treatment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report


Market, By Product

  • Topical products
    • Creams
    • Gels
    • Silicon sheets
    • Other topical products
  • Laser products
    • CO2 laser
    • Pulse-dyed laser
    • Other laser products
  • Injectables
  • Other products

Market, By Type

  • Atrophic scars
  • Hypertrophic and keloid scars
  • Contracture scars
  • Stretch marks

Market, By End-use

  • Hospitals 
  • Clinics
  • Retail pharmacies
  • Medical spa
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The scar treatment industry size was valued at over USD 23.8 billion in 2023 and is estimated to register 9.6% CAGR between 2024 and 2032 led by the rising burden of psoriasis, acne, eczema, and dermatitis, as well as traumatic injuries including surgical incisions, burns, and cuts

The topical products segment in the scar treatment industry will generate over USD 23.6 billion by the end of 2032, driven by growing preference for improved formulations incorporated with ingredients

North America scar treatment industry size will record USD 21.9 billion by 2032, driven by a well-established healthcare infrastructure and advanced medical technology.

CCA Industries, Inc., Clayton, Dubilier & Rice, LLC, Lumenis Be Ltd., McKesson Corporation, Merz Pharma GmbH & Co. KGaA, Newmedical Technology Inc., Perrigo Company plc, SMITH & NEPHEW plc, Sonoma Pharmaceuticals, Inc., and Suneva Medical

Scar Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 229
  • Countries covered: 22
  • Pages: 178
 Download Free Sample